Scientist I - Assay Development - China at Alamar Biosciences

Hangzhou, Zhejiang, China

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Life SciencesIndustries

Requirements

Ph.D. degree in Biochemistry, Molecular Biology. Or MS degree with a minimum of 3 years of industrial experience
Ability to manage projects with a positive “can-do” attitude
Knowledge of emerging reagents, immunoassay technologies, biomarker discovery, assay prototyping, performance optimization, and control system design
Experience in developing multiplex assays or antibody pairs development is desirable
Proficiency in data management is highly beneficial
Good communication skills are required to work effectively within a multidisciplinary team environment
Good command of English listening, speaking, reading and writing

Responsibilities

Design and execute experiments to detect new biomarkers
Carries out data analysis, interprets and evaluates results, ensuring robustness, accuracy, precision, specificity, and sensitivity. Use discretion to complete tasks
Collaborate with cross-functional teams to ensure the timely and accurate completion of deliverables
Frequently solves problems through research of multiple alternatives
Proactively identify opportunities to enhance both product functionality and process efficiency, contributing to continuous improvement
Provide technical guidance and training to junior team members
Develop and document technology and product requirements, protocols, and work instructions, ensuring clarity and compliance with industry standards

Skills

Biochemistry

Molecular Biology

Assay Development

Biomarker Detection

Data Analysis

Immunoassays

Alamar Biosciences

Develops technology for protein detection and measurement

About Alamar Biosciences

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.

Hayward, CaliforniaHeadquarters

2018Year Founded

$225.7MTotal Funding

GRANTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Company Equity

Risks

Increased competition from Olink and SomaLogic may impact Alamar's market share.

Scaling production in Europe and APAC could strain resources and affect quality.

Regulatory hurdles in new regions may delay product launches and affect revenue.

Differentiation

Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.

The ARGO™ system automates high-throughput proteomics, reducing the need for technical expertise.

Alamar's focus on early disease detection sets it apart in the biotechnology field.

Upsides

ISO 13485:2016 certification boosts Alamar's credibility in the medical device industry.

European expansion with Milan headquarters enhances market reach and client service.

$10M investment accelerates Alzheimer's diagnostics development, strengthening Alamar's market position.

Land your dream remote job 3x faster with AI

Try Jobo Free